RxDoctor Payments DataLook up a doctor →

VIABAHN Endoprosthesis with Heparin Bioactive Surface: payments to doctors

Payments that named VIABAHN Endoprosthesis with Heparin Bioactive Surface as the associated device or medical supply, reported under the Sunshine Act for program years 20192025.

Total reported
$90K
Providers
839
Transactions
1,623
Average per transaction
$55

The per-transaction average — $55 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 839 providers the average total is $107, but that average hides a very steep distribution.

Companies reporting these payments

CompanyTotal reportedShare
W. L. Gore & Associates, Inc.$90,046100.0%
← All drugs & devices